These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22133874)

  • 1. Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis.
    Hlady RA; Novakova S; Opavska J; Klinkebiel D; Peters SL; Bies J; Hannah J; Iqbal J; Anderson KM; Siebler HM; Smith LM; Greiner TC; Bastola D; Joshi S; Lockridge O; Simpson MA; Felsher DW; Wagner KU; Chan WC; Christman JK; Opavsky R
    J Clin Invest; 2012 Jan; 122(1):163-77. PubMed ID: 22133874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dnmt3b catalytic activity is critical for its tumour suppressor function in lymphomagenesis and is associated with c-Met oncogenic signalling.
    Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Opavsky R
    EBioMedicine; 2021 Jan; 63():103191. PubMed ID: 33418509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNMT3B7 expression related to MENT expression and its promoter methylation in human lymphomas.
    Alkebsi L; Handa H; Sasaki Y; Osaki Y; Yanagisawa K; Ogawa Y; Yokohama A; Hattori H; Koiso H; Saitoh T; Mitsui T; Tsukamoto N; Nojima Y; Murakami H
    Leuk Res; 2013 Dec; 37(12):1662-7. PubMed ID: 24094886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation-independent repression of Dnmt3b contributes to oncogenic activity of Dnmt3a in mouse MYC-induced T-cell lymphomagenesis.
    Haney SL; Hlady RA; Opavska J; Klinkebiel D; Pirruccello SJ; Dutta S; Datta K; Simpson MA; Wu L; Opavsky R
    Oncogene; 2015 Oct; 34(43):5436-5446. PubMed ID: 25639876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis.
    Shah MY; Vasanthakumar A; Barnes NY; Figueroa ME; Kamp A; Hendrick C; Ostler KR; Davis EM; Lin S; Anastasi J; Le Beau MM; Moskowitz IP; Melnick A; Pytel P; Godley LA
    Cancer Res; 2010 Jul; 70(14):5840-50. PubMed ID: 20587527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreases in different Dnmt3b activities drive distinct development of hematologic malignancies in mice.
    Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Haney SL; Opavsky R
    J Biol Chem; 2021; 296():100285. PubMed ID: 33450231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role for Dnmt1 in the prevention and maintenance of MYC-induced T-cell lymphomas.
    Peters SL; Hlady RA; Opavska J; Klinkebiel D; Novakova S; Smith LM; Lewis RE; Karpf AR; Simpson MA; Wu L; Opavsky R
    Mol Cell Biol; 2013 Nov; 33(21):4321-33. PubMed ID: 24001767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis.
    Vasanthakumar A; Lepore JB; Zegarek MH; Kocherginsky M; Singh M; Davis EM; Link PA; Anastasi J; Le Beau MM; Karpf AR; Godley LA
    Blood; 2013 Mar; 121(11):2059-63. PubMed ID: 23315164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Dnmt3b accelerates MLL-AF9 leukemia progression.
    Zheng Y; Zhang H; Wang Y; Li X; Lu P; Dong F; Pang Y; Ma S; Cheng H; Hao S; Tang F; Yuan W; Zhang X; Cheng T
    Leukemia; 2016 Dec; 30(12):2373-2384. PubMed ID: 27133822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative effects of DNA methyltransferase 3B depletion are not associated with DNA demethylation.
    Hagemann S; Kuck D; Stresemann C; Prinz F; Brueckner B; Mund C; Mumberg D; Sommer A
    PLoS One; 2012; 7(5):e36125. PubMed ID: 22563479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global identification of genes targeted by DNMT3b for epigenetic silencing in lung cancer.
    Teneng I; Tellez CS; Picchi MA; Klinge DM; Yingling CM; Snider AM; Liu Y; Belinsky SA
    Oncogene; 2015 Jan; 34(5):621-30. PubMed ID: 24469050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
    Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
    Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E
    Wong CC; Kang W; Xu J; Qian Y; Luk STY; Chen H; Li W; Zhao L; Zhang X; Chiu PW; Ng EK; Yu J
    Theranostics; 2019; 9(21):6256-6268. PubMed ID: 31534549
    [No Abstract]   [Full Text] [Related]  

  • 14. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.
    Okano M; Bell DW; Haber DA; Li E
    Cell; 1999 Oct; 99(3):247-57. PubMed ID: 10555141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pterostilbene leads to DNMT3B-mediated DNA methylation and silencing of OCT1-targeted oncogenes in breast cancer cells.
    Beetch M; Boycott C; Harandi-Zadeh S; Yang T; Martin BJE; Dixon-McDougall T; Ren K; Gacad A; Dupuis JH; Ullmer M; Lubecka K; Yada RY; Brown CJ; Howe LJ; Stefanska B
    J Nutr Biochem; 2021 Dec; 98():108815. PubMed ID: 34242723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytically inactive Dnmt3b rescues mouse embryonic development by accessory and repressive functions.
    Nowialis P; Lopusna K; Opavska J; Haney SL; Abraham A; Sheng P; Riva A; Natarajan A; Guryanova O; Simpson M; Hlady R; Xie M; Opavsky R
    Nat Commun; 2019 Sep; 10(1):4374. PubMed ID: 31558711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTSS1, a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in hepatocellular carcinoma.
    Fan H; Chen L; Zhang F; Quan Y; Su X; Qiu X; Zhao Z; Kong KL; Dong S; Song Y; Chan TH; Guan XY
    Oncogene; 2012 May; 31(18):2298-308. PubMed ID: 21909138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ∆ DNMT3B4-del Contributes to Aberrant DNA Methylation Patterns in Lung Tumorigenesis.
    Ma MZ; Lin R; Carrillo J; Bhutani M; Pathak A; Ren H; Li Y; Song J; Mao L
    EBioMedicine; 2015 Oct; 2(10):1340-50. PubMed ID: 26629529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methyltransferase deficiency modifies cancer susceptibility in mice lacking DNA mismatch repair.
    Trinh BN; Long TI; Nickel AE; Shibata D; Laird PW
    Mol Cell Biol; 2002 May; 22(9):2906-17. PubMed ID: 11940649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaempferol Modulates DNA Methylation and Downregulates DNMT3B in Bladder Cancer.
    Qiu W; Lin J; Zhu Y; Zhang J; Zeng L; Su M; Tian Y
    Cell Physiol Biochem; 2017; 41(4):1325-1335. PubMed ID: 28278502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.